相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)
Richard Dillon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso et al.
CELL (2021)
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren et al.
NATURE (2021)
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Laura M. Richards et al.
NATURE CANCER (2021)
The evolution of alternative splicing in glioblastoma under therapy
Lin Wang et al.
GENOME BIOLOGY (2021)
Tracing evolution reveals new biomarkers
Peter Sidaway
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
Khalid AbdulJabbar et al.
NATURE MEDICINE (2020)
Lineage tracing meets single-cell omics: opportunities and challenges
Daniel E. Wagner et al.
NATURE REVIEWS GENETICS (2020)
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
S. J. Schraa et al.
BMC CANCER (2020)
Protocol A Patient-Derived Xenograft Model of Glioblastoma
Chirayu R. Chokshi et al.
STAR PROTOCOLS (2020)
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Koerber et al.
CANCER CELL (2019)
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M. Miller et al.
NATURE (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Clinical lessons learned from the first leg of the CAR T cell journey
Robbie G. Majzner et al.
NATURE MEDICINE (2019)
CancerSEA: a cancer single-cell state atlas
Huating Yuan et al.
NUCLEIC ACIDS RESEARCH (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
Alyssa M. Vanderbeek et al.
NEURO-ONCOLOGY (2018)
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Xiaoyang Lan et al.
NATURE (2017)
An immunocompetent mouse model of human glioblastoma
Samantha Semenkow et al.
ONCOTARGET (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors
Edyta E. Wojtowicz et al.
CELL STEM CELL (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
Cristina Richichi et al.
ONCOTARGET (2016)
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells
Chitra Venugopal et al.
CLINICAL CANCER RESEARCH (2015)
MStern Blotting-High Throughput Polyvinylidene Fluoride (PVDF) Membrane-Based Proteomic Sample Preparation for 96-Well Plates
Sebastian T. Berger et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Cancer Evolution Constrained by Mutation Order
Charles Swanton
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Myelin mapping in the living mouse brain using manganese-enhanced magnetization transfer MRI
Takashi Watanabe et al.
NEUROIMAGE (2010)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
